diabetes

FDA gives Novo Nordisk top grades for its diabetes drug semaglutide, but retinopathy remains key
Endpoints
Mon, 10/16/17 - 09:42 am
FDA
Novo Nordisk
diabetes
semaglutide
diabetic retinopathy
Here’s how the diabetes industry’s leaders think about patient-centered R&D
Drug Delivery Business News
Wed, 10/11/17 - 11:11 pm
diabetes
R&D
patients
patient-centered R&D
J&J Dumps Insulin Pumps – Who Has the Most to Gain?
Medical Device and Diagnostic Industry
Sun, 10/8/17 - 11:19 am
JNJ
insulin pumps
Animas
Medtronic
diabetes
devices
FDA approves new label language for Afrezza
Greenwich Citizen, CT
Thu, 10/5/17 - 04:48 pm
FDA
labeling
Afrezza
inhaled insulin
MannKind
diabetes
Why MannKind Stock Started October With a Bang
Motley Fool
Mon, 10/2/17 - 10:14 pm
MannKind
inhaled insulin
Afrezza
diabetes
Why Bigfoot Biomedical’s CEO thinks the diabetes industry has a data problem
Drug Delivery Business News
Sun, 10/1/17 - 10:00 am
Bigfoot Biomedical
Abbott Labs
diabetes
FreeStyle Libre Flash
Novo Nordisk wins FDA nod for fast-acting mealtime insulin
Drug Delivery Business News
Sat, 09/30/17 - 10:20 am
Novo Nordisk
FDA
diabetes
insulin
Fiasp
FDA approves first glucose sensing tech that doesn’t require routine finger sticks
Drug Delivery Business News
Thu, 09/28/17 - 09:46 am
FDA
Abbott Labs
devices
diabetes
blood glucose monitoring
FreeStyle Libre Flash
Boehringer's new risk-prediction model will tap patients who could be good Jardiance candidates
Fierce Pharma
Wed, 09/27/17 - 11:19 am
Boehringer Ingelheim
Eli Lilly
Jardiance
diabetes
3 Ways AI Is Changing Medicine
Motley Fool
Thu, 09/21/17 - 08:30 am
artificial intelligence
Gritstone Oncology
Alphabet
cancer immunotherapy
IBM Watson
Pfizer
Google Brain
diabetes
retinal blindness
HeartFlow
Verily
Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Fierce Pharma
Mon, 09/18/17 - 11:08 am
Sanofi
Amgen
PCSK9 inhibitors
diabetes
Regeneron
Praluent
Repatha
Severe hypoglycemia multiplies death risk up to fourfold in diabetes, Novo Nordisk finds
Fierce Pharma
Fri, 09/15/17 - 11:19 am
Novo Nordisk
diabetes
hypoglycemia
EASD
AstraZeneca's Bydureon fails to show cardio-protection
BioPharma Dive
Thu, 09/14/17 - 10:05 pm
EASD
AstraZeneca
Bydureon
diabetes
EASD: Boehringer Ingelheim, Lilly's Jardiance holds CV benefit regardless of blood sugar starting point
Fierce Pharma
Thu, 09/14/17 - 11:27 am
EASD
Boehringer Ingelheim
Eli Lilly
Jardiance
diabetes
EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 study
Fierce Pharma
Thu, 09/14/17 - 09:56 am
EASD
AstraZeneca
Farixga
diabetes
EASD: Sanofi's Toujeo bests Lantus at holding off hypoglycemia, studies show
Fierce Pharma
Thu, 09/14/17 - 09:45 am
Sanofi
EASD
Toujeo
Lantus
hypoglycemia
diabetes
MannKind - Afrezza Scripts Finish August Flat
Seeking Alpha
Sun, 09/10/17 - 11:47 am
MannKind
Afrezza
diabetes
inhaled insulin
Big pharma stands to make hundreds of billions of dollars from a handful of medical conditions
Motley Fool
Thu, 09/7/17 - 09:56 am
Big Pharma
viral hepatitis
respiratory disease
autoimmune disease
cardiovascular disease
pain
diabetes
cancer
Sanofi wins tentative FDA nod for Admelog insulin lispro injection
Drug Delivery Business News
Fri, 09/1/17 - 06:50 pm
Sanofi
FDA
Admelog insulin lispro
diabetes
Novo’s Victoza, new indication to reduce CV risk
GoInPharma
Sun, 08/27/17 - 06:24 pm
Novo Nordisk
Victoza
diabetes
cardiovascular disease

Pages